Azure Health Technology Limited (NSX:VTL) Receipt of Finished Nutraceutical Products abnnewswire.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abnnewswire.net Daily Mail and Mail on Sunday newspapers.
Azure Health Technology Limited (NSX:VTL) Appointment of cGMP Manufacturer
Appointment of cGMP ManufacturerSydney, June 7, 2021 AEST (ABN Newswire) - Azure Health Technology Limited trading as VGI Health Technology (
NSX:VTL) is pleased to announce that an additional current Good Manufacturing Practice (cGMP) manufacturer has been appointed in the US.
VTL has executed a Manufacturing and Supply Agreement with Altipure LLC, a clinical partner of Muscle Feast, LLC in Ohio, USA, after the completion of a pilot manufacturing project which produced clinical study drugs for VTL s two Phase II clinical studies.
In this pilot manufacturing run which has recently been completed, 60,000 doses of active clinical study drug and 60,000 doses of placebo were manufactured and are expected to arrive in Australia in July 2021.
NSX:VTL ISIN:AU0000152597
Azure Health Technology Limited (NSX:AZT) develops and commercializes evidence-based nutraceuticals and pharmaceuticals based on two proprietary and patented delivery platforms for improving the bioavailability and efficacy of tocotrienols (a natural product which is one part of vitamin E).